Stay updated with breaking news from Advanced Technology Platforms. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
As COVID-19 rapidly expanded throughout the world in April 2020, many in the biomedical technology community voiced significant concerns about the lack of available diagnostic tests. At that time, testing for SARS-CoV-2, the coronavirus that causes COVID-19, was conducted exclusively in clinical laboratories by order of a health-care provider. “Over the counter” (OTC) tests did…
/PRNewswire/ -- BioFluidica, a privately held biotechnology company, today announced they have been awarded a continuation grant from the Midwest Biomedical...
The new impact calculator indicates whether a person should get a test.
Demand is increasing for COVID-19 testing among individuals and families, especially as winter approaches and people shift to indoor activities. The
The NIH RADx initiative announced today that it has issued contract awards totaling $77.7 million to develop and manufacture 12 new rapid diagnostic tests for SARS-CoV-2, the virus that causes COVID-19. The home and point-of-care testing platforms target the need for high-performance, low-cost home tests and point-of-care tests that can potentially detect multiple respiratory infections.